혈액 여과 및 정화 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Blood Filtration and Purification Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End User, By Region and Competition, 2020-2030F
혈액 여과 및 정화 세계 시장은 2024년에 38억 1,000만 달러로 평가되고 2030년에는 58억 2,000만 달러에 달할 것으로 예상되며, 예측 기간 동안 7.29%의 CAGR로 성장할 것으로 예상됩니다.
이 시장은 만성질환 및 혈액 관련 질환의 유병률 증가와 함께 임상 현장에서 고급 여과 기술에 대한 인식이 높아짐에 따라 빠르게 성장하고 있습니다. 혈액 정화 기술은 패혈증, 만성 신장 질환, 각종 감염성 질환 등의 질병 관리에 필수적이며, 현대 의료 서비스 제공에 필수적인 요소로 자리 잡고 있습니다. 마이크로 및 나노 여과 시스템의 기술 혁신은 치료의 효율성과 정확성을 향상시키고, 외과 수술의 증가로 병원, 진단 실험실 및 클리닉에서 제품 수요가 더욱 증가하고 있습니다. 또한, 의료비 지출의 증가와 자동화된 AI 통합 여과 시스템의 채택은 시술의 간소화와 환자 결과의 개선에 도움이 되고 있습니다. 점점 더 많은 의료 서비스 제공자가 첨단 기술을 채택하여 진화하는 의료 수요에 대응함에 따라 혈액 여과 및 정화 시장은 안정적인 성장을 보일 것으로 예상됩니다.
| 시장 개요 |
| 예측 기간 |
2026-2030년 |
| 시장 규모 : 2024년 |
38억 1,000만 달러 |
| 시장 규모 : 2030년 |
58억 2,000만 달러 |
| CAGR : 2025-2030년 |
7.29% |
| 급성장 부문 |
유전자 및 분자 진단 |
| 최대 시장 |
북미 |
시장 촉진요인
만성질환 발생률 증가
주요 시장 과제
고도의 여과 장비의 높은 비용
주요 시장 동향
혈액 여과 치료의 개별화
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 혈액 여과 및 정화 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 제품별(여과 키트 및 시약, 막, 필터 및 소모품, 샘플 조제 시스템, 특수 어세이 및 컬럼)
- 용도별(감염증 진단, 독물학 및 면역진단, 암 진단, 유전자/분자진단, 기타)
- 최종사용자별(임상 진단 실험실, 병원, 조사·학술기관, 기타)
- 기업별(2024)
- 지역별
- 시장 맵
제6장 북미의 혈액 여과 및 정화 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 북미 : 국가별 분석
제7장 유럽의 혈액 여과 및 정화 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 유럽 : 국가별 분석
제8장 아시아태평양의 혈액 여과 및 정화 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 아시아태평양 : 국가별 분석
제9장 남미의 혈액 여과 및 정화 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 남미 : 국가별 분석
제10장 중동 및 아프리카의 혈액 여과 및 정화 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 중동 및 아프리카 : 국가별 분석
제11장 시장 역학
제12장 시장 동향과 발전
제13장 Porter's Five Forces 분석
- 업계내 경쟁
- 신규 참여의 가능성
- 공급업체의 능력
- 고객의 능력
- 대체품의 위협
제14장 경쟁 구도
- Thermo Fischer Scientific
- MilliporeSigma
- Roche lifescience
- Sigma Aldrich
- Avantor
- Takara Bio
- MP Biomedicals.
- QIAGEN N.V
- HiMedia
- Biotage
제15장 전략적 제안
제16장 조사 회사 소개 및 면책사항
ksm
The Global Blood Filtration and Purification Market was valued at USD 3.81 Billion in 2024 and is projected to reach USD 5.82 Billion by 2030, growing at a CAGR of 7.29% during the forecast period. This market is expanding rapidly due to the increasing prevalence of chronic and blood-related conditions, coupled with growing awareness of advanced filtration technologies in clinical settings. Blood purification technologies are essential in the management of diseases such as sepsis, chronic kidney disease, and various infections, making them critical to modern healthcare delivery. Innovations in micro- and nano-filtration systems have enhanced the efficiency and precision of treatment, while the rising number of surgical interventions has further fueled product demand across hospitals, diagnostic labs, and clinics. Additionally, higher healthcare spending and the adoption of automated, AI-integrated filtration systems are helping streamline procedures and improve patient outcomes. As more healthcare providers adopt advanced technologies to meet evolving medical needs, the market for blood filtration and purification is poised for steady growth.
| Market Overview |
|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 3.81 Billion |
| Market Size 2030 | USD 5.82 Billion |
| CAGR 2025-2030 | 7.29% |
| Fastest Growing Segment | Genetic/Molecular Diagnostics |
| Largest Market | North America |
Key Market Drivers
Rising Incidence of Chronic Diseases
The growing burden of chronic diseases globally is a key factor driving the Blood Filtration and Purification Market. Conditions such as chronic kidney disease (CKD), diabetes, cardiovascular diseases (CVDs), and autoimmune disorders are increasingly common, resulting in a heightened need for filtration therapies. Over 850 million people suffer from CKD, which often requires dialysis-a treatment dependent on blood purification systems. Similarly, with approximately 830 million people living with diabetes as of 2022, diabetic nephropathy is rising, increasing the demand for blood filtration devices. Cardiovascular diseases, responsible for 17.9 million deaths annually, often lead to fluid overload and toxin buildup, necessitating blood purification treatments. Moreover, autoimmune diseases like rheumatoid arthritis can cause systemic issues, requiring therapies to filter harmful antibodies. With aging populations and growing disease prevalence, the demand for advanced blood purification technologies continues to surge globally.
Key Market Challenges
High Costs of Advanced Filtration Devices
The adoption of advanced blood filtration technologies is limited by the high cost of devices and associated maintenance. These systems often utilize specialized membranes, smart sensors, and integrated AI functionalities, increasing manufacturing and operational expenses. Such high-cost technologies are out of reach for many smaller healthcare providers, especially in developing economies. Additionally, reimbursement gaps in various healthcare systems create financial uncertainty, deterring investment in premium filtration solutions. With limited insurance coverage and minimal government subsidies, the return on investment for hospitals remains a concern. Furthermore, supply chain limitations and high costs of sourcing raw materials hinder affordability. These cost-related barriers not only restrict access but also slow the broader adoption of advanced blood purification across global markets.
Key Market Trends
Personalization of Blood Filtration Treatments
The blood filtration landscape is evolving toward personalized treatment approaches, supported by real-time diagnostics and AI-driven clinical decision-making. Healthcare providers are increasingly customizing filtration therapies based on patient-specific data, including biomarker levels, comorbid conditions, and treatment responses. This trend is especially prevalent in critical care environments where rapid and precise intervention is essential. AI and machine learning tools are now being used to adjust filtration parameters dynamically, enhancing treatment outcomes and minimizing side effects. Biosensor integration and wearable monitoring technologies are also contributing to this shift, enabling continuous patient evaluation and better decision-making. Manufacturers are responding by introducing modular systems and patient-tailored filtration kits. As the healthcare system increasingly emphasizes individualized, outcome-focused care, the trend toward personalized blood purification is expected to become mainstream in both acute and chronic care settings.
Key Market Players
- Thermo Fischer Scientific
- MilliporeSigma
- Roche lifescience
- Sigma Aldrich
- Avantor
- Takara Bio
- MP Biomedicals
- QIAGEN N.V
- HiMedia
- Biotage
Report Scope
In this report, the Global Blood Filtration and Purification Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Blood Filtration and Purification Market, By Product:
- Filtration Kits and Reagents
- Membranes, Filters and Consumables
- Sample Preparation Systems
- Specialty Assays and Columns
Blood Filtration and Purification Market, By Application:
- Infectious Disease Diagnostics
- Toxicology and Immunodiagnostics
- Cancer Diagnostics
- Genetic/Molecular Diagnostics
- Others
Blood Filtration and Purification Market, By End User:
- Clinical Diagnostic Labs
- Hospitals
- Research and Academic Institutes
- Others
Blood Filtration and Purification Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Blood Filtration and Purification Market.
Available Customizations
Global Blood Filtration and Purification Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global Blood Filtration and Purification Market Outlook
- 5.1. Market Size & Forecast
- 5.2. Market Share & Forecast
- 5.2.1. By Product (Filtration Kits and Reagents, Membranes, Filters and Consumables, Sample Preparation Systems, Specialty Assays and Columns)
- 5.2.2. By Application (Infectious Disease Diagnostics, Toxicology and Immunodiagnostics, Cancer Diagnostics, Genetic/Molecular Diagnostics, Others)
- 5.2.3. By End User (Clinical Diagnostic Labs, Hospitals, Research and Academic Institutes, Others)
- 5.2.4. By Company (2024)
- 5.2.5. By Region
- 5.3. Market Map
6. North America Blood Filtration and Purification Market Outlook
- 6.1. Market Size & Forecast
- 6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Application
- 6.2.3. By End User
- 6.2.4. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Blood Filtration and Purification Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Product
- 6.3.1.2.2. By Application
- 6.3.1.2.3. By End User
- 6.3.2. Mexico Blood Filtration and Purification Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Product
- 6.3.2.2.2. By Application
- 6.3.2.2.3. By End User
- 6.3.3. Canada Blood Filtration and Purification Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Product
- 6.3.3.2.2. By Application
- 6.3.3.2.3. By End User
7. Europe Blood Filtration and Purification Market Outlook
- 7.1. Market Size & Forecast
- 7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Application
- 7.2.3. By End User
- 7.2.4. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. France Blood Filtration and Purification Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Product
- 7.3.1.2.2. By Application
- 7.3.1.2.3. By End User
- 7.3.2. Germany Blood Filtration and Purification Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Product
- 7.3.2.2.2. By Application
- 7.3.2.2.3. By End User
- 7.3.3. United Kingdom Blood Filtration and Purification Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Product
- 7.3.3.2.2. By Application
- 7.3.3.2.3. By End User
- 7.3.4. Italy Blood Filtration and Purification Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Product
- 7.3.4.2.2. By Application
- 7.3.4.2.3. By End User
- 7.3.5. Spain Blood Filtration and Purification Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Product
- 7.3.5.2.2. By Application
- 7.3.5.2.3. By End User
8. Asia-Pacific Blood Filtration and Purification Market Outlook
- 8.1. Market Size & Forecast
- 8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Application
- 8.2.3. By End User
- 8.2.4. By Country
- 8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Blood Filtration and Purification Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Product
- 8.3.1.2.2. By Application
- 8.3.1.2.3. By End User
- 8.3.2. India Blood Filtration and Purification Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Product
- 8.3.2.2.2. By Application
- 8.3.2.2.3. By End User
- 8.3.3. South Korea Blood Filtration and Purification Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Product
- 8.3.3.2.2. By Application
- 8.3.3.2.3. By End User
- 8.3.4. Japan Blood Filtration and Purification Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Product
- 8.3.4.2.2. By Application
- 8.3.4.2.3. By End User
- 8.3.5. Australia Blood Filtration and Purification Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Product
- 8.3.5.2.2. By Application
- 8.3.5.2.3. By End User
9. South America Blood Filtration and Purification Market Outlook
- 9.1. Market Size & Forecast
- 9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Application
- 9.2.3. By End User
- 9.2.4. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil Blood Filtration and Purification Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Product
- 9.3.1.2.2. By Application
- 9.3.1.2.3. By End User
- 9.3.2. Argentina Blood Filtration and Purification Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Product
- 9.3.2.2.2. By Application
- 9.3.2.2.3. By End User
- 9.3.3. Colombia Blood Filtration and Purification Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Product
- 9.3.3.2.2. By Application
- 9.3.3.2.3. By End User
10. Middle East and Africa Blood Filtration and Purification Market Outlook
- 10.1. Market Size & Forecast
- 10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Application
- 10.2.3. By End User
- 10.2.4. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Blood Filtration and Purification Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Product
- 10.3.1.2.2. By Application
- 10.3.1.2.3. By End User
- 10.3.2. Saudi Arabia Blood Filtration and Purification Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Product
- 10.3.2.2.2. By Application
- 10.3.2.2.3. By End User
- 10.3.3. UAE Blood Filtration and Purification Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Product
- 10.3.3.2.2. By Application
- 10.3.3.2.3. By End User
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Merger & Acquisition (If Any)
- 12.2. Product Launches (If Any)
- 12.3. Recent Developments
13. Porters Five Forces Analysis
- 13.1. Competition in the Industry
- 13.2. Potential of New Entrants
- 13.3. Power of Suppliers
- 13.4. Power of Customers
- 13.5. Threat of Substitute Products
14. Competitive Landscape
- 14.1. Thermo Fischer Scientific
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (As Reported)
- 14.1.5. Recent Developments
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
- 14.2. MilliporeSigma
- 14.3. Roche lifescience
- 14.4. Sigma Aldrich
- 14.5. Avantor
- 14.6. Takara Bio
- 14.7. MP Biomedicals.
- 14.8. QIAGEN N.V
- 14.9. HiMedia
- 14.10. Biotage
15. Strategic Recommendations
16. About Us & Disclaimer
